臧敬五的文章终于被退稿了,尘埃落定了# Biology - 生物学
X*4
1 楼
Retraction: Crucial role of interleukin-7 in T helper type 17 survival and
expansion in autoimmune disease
The above manuscript was authored by scientists from the GlaxoSmithKline (
GSK) Research and Development Center in Shanghai, China, and a researcher
from Baylor Medical College who later became a GSK employee. Following
anonymous reports of inaccuracies in this study, GSK conducted an
investigation into these allegations.
The investigation established that the data depicted in Figure 6 and in
Supplementary Figure 7 were erroneously attributed to experiments at Baylor
Medical College with blood cells from patients with multiple sclerosis. In
fact, no data from experiments with blood cells from patients with multiple
sclerosis and no data from experiments at Baylor Medical College were
included in the paper. GSK has therefore concluded that the paper contains
erroneous data and requests that it be retracted.
All authors agreed to the retraction of the paper with the following
exceptions and clarifications. Xuebin Liu and Stewart Leung declined to sign
the retraction and stand by the conclusions of the paper. Chunxia Wang, Xia
Qin and Limin Lu did not respond to Nature Medicine's requests for comment
on the retraction. Ji Wang, Lei Fang, Bing Wan, Jian Hong and Hongtao Lu
could not be reached by the journal for comment on the retraction. However,
Chunxia Wang, Xia Qin, Limin Lu, Ji Wang, Lei Fang, Bing Wan, Jian Hong and
Hongtao Lu signed an initial version of the retraction submitted to the
journal by GSK.
expansion in autoimmune disease
The above manuscript was authored by scientists from the GlaxoSmithKline (
GSK) Research and Development Center in Shanghai, China, and a researcher
from Baylor Medical College who later became a GSK employee. Following
anonymous reports of inaccuracies in this study, GSK conducted an
investigation into these allegations.
The investigation established that the data depicted in Figure 6 and in
Supplementary Figure 7 were erroneously attributed to experiments at Baylor
Medical College with blood cells from patients with multiple sclerosis. In
fact, no data from experiments with blood cells from patients with multiple
sclerosis and no data from experiments at Baylor Medical College were
included in the paper. GSK has therefore concluded that the paper contains
erroneous data and requests that it be retracted.
All authors agreed to the retraction of the paper with the following
exceptions and clarifications. Xuebin Liu and Stewart Leung declined to sign
the retraction and stand by the conclusions of the paper. Chunxia Wang, Xia
Qin and Limin Lu did not respond to Nature Medicine's requests for comment
on the retraction. Ji Wang, Lei Fang, Bing Wan, Jian Hong and Hongtao Lu
could not be reached by the journal for comment on the retraction. However,
Chunxia Wang, Xia Qin, Limin Lu, Ji Wang, Lei Fang, Bing Wan, Jian Hong and
Hongtao Lu signed an initial version of the retraction submitted to the
journal by GSK.
